Brussels, 27/07/2016 (Agence Europe) - The European Medicines Agency (EMA) has recommended that European Union (EU) member states should drastically reduce the use of colistin in animals on their territory. In an opinion published on Wednesday 27 July, it even went as far as calling for reducing sales by two thirds.
Colistin is a molecule used as a last resort in the event of recurring bacterial infection. It was authorised at the end of the 1950s to treat acute and chronic infections...